DB
GRI

Danske Bank’s GRI Bio GRI Stock Holding History

Danske Bank’s Portfolio GRI Stock Details GRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4 Hold
2
– – ﹤0.01% 1101
2026
Q1 		$5 Buy
+2
New +$7 ﹤0.01% 1106

Other funds holding GRI

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

Danske Bank's GRI Position: Q2 2026 in Review

Danske Bank held its GRI Bio (GRI) position steady in Q2 2026 at 2 shares worth $4. The position accounts for ﹤0.01% of the portfolio, ranked #1101.

Danske Bank first reported a position in GRI in Q1 2026 and has held it in 2 quarters since. The position peaked at $5 in Q1 2026. 8 funds tracked by Wall St. Rank hold GRI as of Q2 2026.

  • Danske Bank held 2 shares of GRI Bio worth $4 as of Q2 2026.
  • Danske Bank left its GRI Bio share count unchanged in Q2 2026.
  • GRI Bio made up ﹤0.01% of Danske Bank's portfolio in Q2 2026, its #1101 holding.
  • Danske Bank first reported a position in GRI Bio in Q1 2026 and has held it in 2 quarters since.
  • Danske Bank's GRI Bio position peaked at $5 in Q1 2026.
  • 8 funds tracked by Wall St. Rank held GRI Bio as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.